$SYBX
SYNLOGIC, INC.

2020 Q1 Form 10-K Financial Statement

#000156459020010261 Filed on March 12, 2020

View on sec.gov

Income Statement

Concept 2020 Q1 2019 Q4 2019
Revenue $100.0K $1.231M $2.224M
YoY Change -70.41% 1009.01% -11.75%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $3.820M $3.460M $14.73M
YoY Change 4.66% -12.41% -6.3%
% of Gross Profit
Research & Development $12.68M $11.25M $41.91M
YoY Change 22.08% 26.83% 10.18%
% of Gross Profit
Depreciation & Amortization $667.0K -$290.0K $2.700M
YoY Change -25.89% -146.03% 11.52%
% of Gross Profit
Operating Expenses $16.50M $14.71M $56.63M
YoY Change 17.55% 14.75% 5.36%
Operating Profit -$16.40M -$13.48M -$54.41M
YoY Change 19.72% 6.07% 6.21%
Interest Expense $570.0K $690.0K $21.00K
YoY Change 8042.86% -11.54% -51.16%
% of Operating Profit
Other Income/Expense, Net $570.0K $0.00 $3.036M
YoY Change -24.1% 8.62%
Pretax Income -$15.83M -$12.80M -$51.37M
YoY Change 22.24% 7.29% 6.05%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$15.83M -$12.80M -$51.37M
YoY Change 22.26% 7.27% 6.07%
Net Earnings / Revenue -15828.0% -1039.64% -2309.94%
Basic Earnings Per Share
Diluted Earnings Per Share -$462.5K -$373.5K -$1.696M
COMMON SHARES
Basic Shares Outstanding 32.25M
Diluted Shares Outstanding

Balance Sheet

Concept 2020 Q1 2019 Q4 2019
SHORT-TERM ASSETS
Cash & Short-Term Investments $114.2M $119.6M $119.6M
YoY Change 3.97% -2.57% -2.53%
Cash & Equivalents $20.55M $26.18M $26.20M
Short-Term Investments $94.80M $93.39M $93.40M
Other Short-Term Assets $13.20M $648.0K $13.60M
YoY Change 780.0% 67.01% 750.0%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $127.4M $133.2M $133.2M
YoY Change 11.95% 7.16% 7.16%
LONG-TERM ASSETS
Property, Plant & Equipment $29.50M $13.02M $30.30M
YoY Change -1.67% -12.26% 104.73%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $0.00 $7.500M $7.500M
YoY Change
Other Assets $14.20M $64.00K $17.50M
YoY Change 21746.15% 0.0% 1358.33%
Total Long-Term Assets $43.70M $55.33M $55.40M
YoY Change 40.06% 245.76% 246.25%
TOTAL ASSETS
Total Short-Term Assets $127.4M $133.2M $133.2M
Total Long-Term Assets $43.70M $55.33M $55.40M
Total Assets $171.1M $188.6M $188.6M
YoY Change 18.0% 34.37% 34.43%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.700M $2.165M $2.200M
YoY Change -28.54% -10.57% -8.33%
Accrued Expenses $4.500M $3.946M $5.900M
YoY Change 15.95% -20.97% 18.0%
Deferred Revenue $544.0K
YoY Change 102.99%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $100.0K $200.0K $200.0K
YoY Change -66.67% -33.33% -33.33%
Total Short-Term Liabilities $6.800M $8.863M $8.900M
YoY Change -31.08% 6.26% 7.23%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0% -100.0% -100.0%
Other Long-Term Liabilities $22.20M $22.80M $22.80M
YoY Change -2.63% 196.1% 196.1%
Total Long-Term Liabilities $22.20M $22.81M $22.80M
YoY Change -3.06% 188.65% 188.61%
TOTAL LIABILITIES
Total Short-Term Liabilities $6.800M $8.863M $8.900M
Total Long-Term Liabilities $22.20M $22.81M $22.80M
Total Liabilities $29.00M $31.67M $31.70M
YoY Change -11.59% 94.98% 95.68%
SHAREHOLDERS EQUITY
Retained Earnings -$171.1M
YoY Change 42.89%
Common Stock $327.9M
YoY Change 34.44%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $142.1M $156.9M $156.9M
YoY Change
Total Liabilities & Shareholders Equity $171.1M $188.6M $188.6M
YoY Change 18.0% 34.37% 34.43%

Cashflow Statement

Concept 2020 Q1 2019 Q4 2019
OPERATING ACTIVITIES
Net Income -$15.83M -$12.80M -$51.37M
YoY Change 22.26% 7.27% 6.07%
Depreciation, Depletion And Amortization $667.0K -$290.0K $2.700M
YoY Change -25.89% -146.03% 11.52%
Cash From Operating Activities -$12.48M -$11.22M -$75.47M
YoY Change -4.87% 25.22% 77.7%
INVESTING ACTIVITIES
Capital Expenditures $266.0K -$410.0K $1.251M
YoY Change 1.92% -70.71% -77.87%
Acquisitions
YoY Change
Other Investing Activities $6.080M $10.42M $12.05M
YoY Change -66.11% 141.76% -114.78%
Cash From Investing Activities $5.817M $10.01M $10.80M
YoY Change -67.09% 242.81% -112.38%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $57.00M
YoY Change -31.05%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -69.00K -70.00K 79.60M
YoY Change 6.15% -275.0% -3.49%
NET CHANGE
Cash From Operating Activities -12.48M -11.22M -75.47M
Cash From Investing Activities 5.817M 10.01M 10.80M
Cash From Financing Activities -69.00K -70.00K 79.60M
Net Change In Cash -6.731M -1.280M 14.93M
YoY Change -249.84% -78.67% -131.64%
FREE CASH FLOW
Cash From Operating Activities -$12.48M -$11.22M -$75.47M
Capital Expenditures $266.0K -$410.0K $1.251M
Free Cash Flow -$12.75M -$10.81M -$76.72M
YoY Change -4.74% 42.99% 59.42%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2019Q2 dei Entity Public Float
EntityPublicFloat
161900000
CY2019 dei Entity File Number
EntityFileNumber
001-37566
CY2019 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
26-1824804
CY2019 dei Document Transition Report
DocumentTransitionReport
false
CY2019 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2019 dei Entity Address Address Line1
EntityAddressAddressLine1
301 Binney St
CY2019 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 402
CY2019 dei Entity Address City Or Town
EntityAddressCityOrTown
Cambridge
CY2019 dei Document Annual Report
DocumentAnnualReport
true
CY2019 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
14728000
CY2020Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
32250814
CY2019 dei Entity Ex Transition Period
EntityExTransitionPeriod
true
CY2018 us-gaap Revenues
Revenues
2520000
CY2019 dei Entity Small Business
EntitySmallBusiness
true
CY2019 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2019 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2018 us-gaap Net Income Loss
NetIncomeLoss
-48435000
CY2019 dei Entity Address State Or Province
EntityAddressStateOrProvince
MA
CY2019 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
02142
CY2019 dei City Area Code
CityAreaCode
617
CY2019 dei Local Phone Number
LocalPhoneNumber
401-9975
CY2019 dei Security12b Title
Security12bTitle
Common Stock, par value $0.001 per share
CY2019 dei Entity Shell Company
EntityShellCompany
false
CY2019 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2018 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
15716000
CY2019 us-gaap Revenues
Revenues
2224000
CY2018 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
38034000
CY2019 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
41905000
CY2019Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
2165000
CY2019Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
3946000
CY2019Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
544000
CY2019Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
2000
CY2019Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
22806000
CY2019 us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
3062000
CY2019 us-gaap Interest Expense
InterestExpense
21000
CY2019 us-gaap Net Income Loss
NetIncomeLoss
-51373000
CY2019Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2019Q4 us-gaap Common Stock Value
CommonStockValue
33000
CY2019Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
327900000
CY2019Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
110000
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-171138000
CY2019Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
64000
CY2019Q4 us-gaap Assets
Assets
188574000
CY2019Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
208000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
156905000
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
188574000
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
32266814
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
32266814
CY2019 us-gaap Operating Expenses
OperatingExpenses
56633000
CY2019 us-gaap Operating Income Loss
OperatingIncomeLoss
-54409000
CY2019 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-5000
CY2019 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
3036000
CY2019 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.70
CY2019 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
30284068
CY2019 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
175000
CY2019 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-51198000
CY2018Q4 us-gaap Assets Current
AssetsCurrent
124338000
CY2018Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
14841000
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
26184000
CY2018Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
11252000
CY2019Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
93387000
CY2018Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
111477000
CY2019Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
13675000
CY2018Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1609000
CY2019Q4 us-gaap Assets Current
AssetsCurrent
133246000
CY2019Q4 us-gaap Available For Sale Securities Debt Securities Noncurrent
AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
7502000
CY2019Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
17263000
CY2018Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
1097000
CY2019Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2000000
CY2018Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
266000
CY2018Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
210000
CY2018Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2018Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
7901000
CY2018Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2018Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000
CY2018 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-5000
CY2018 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-2.03
CY2018Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
25401479
CY2018Q4 us-gaap Common Stock Value
CommonStockValue
25000
CY2018 us-gaap Profit Loss
ProfitLoss
-48435000
CY2018Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-65000
CY2018Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-119765000
CY2018 us-gaap Operating Expenses
OperatingExpenses
53750000
CY2018Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
243903000
CY2018 us-gaap Operating Income Loss
OperatingIncomeLoss
-51230000
CY2018 us-gaap Interest Expense
InterestExpense
43000
CY2018 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
2795000
CY2018 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
23882685
CY2018 us-gaap Depreciation
Depreciation
2421000
CY2019 us-gaap Share Based Compensation
ShareBasedCompensation
4134000
CY2018 us-gaap Share Based Compensation
ShareBasedCompensation
4317000
CY2019 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
1282000
CY2018 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
1401000
CY2018 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
45000
CY2018 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-257000
CY2018 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-520000
CY2019 sybx Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-1716000
CY2019 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-75468000
CY2018 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-42470000
CY2019 us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
145418000
CY2018 us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
172887000
CY2018 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
82483000
CY2018 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-47188000
CY2017Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
59537000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
27281000
CY2018 sybx Noncash Purchase Of Property Plant And Equipment In Accounts Payable And Accrued Liabilities Adjustments
NoncashPurchaseOfPropertyPlantAndEquipmentInAccountsPayableAndAccruedLiabilitiesAdjustments
169000
CY2018 us-gaap Interest Paid Net
InterestPaidNet
43000
CY2018 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-168000
CY2019 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-935000
CY2019 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
276000
CY2018 us-gaap Increase Decrease In Deferred Liabilities
IncreaseDecreaseInDeferredLiabilities
1274000
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
13021000
CY2019Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
1097000
CY2019Q4 sybx Prepaid Research And Development Noncurrent
PrepaidResearchAndDevelopmentNoncurrent
16381000
CY2018Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
64000
CY2018Q4 us-gaap Assets
Assets
140340000
CY2018Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
2421000
CY2018Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4993000
CY2018Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
268000
CY2018Q4 us-gaap Deferred Rent Credit Current
DeferredRentCreditCurrent
393000
CY2019Q4 us-gaap Liabilities Current
LiabilitiesCurrent
8863000
CY2018Q4 us-gaap Liabilities Current
LiabilitiesCurrent
8341000
CY2018Q4 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
7691000
CY2019Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
22804000
CY2018Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
25401479
CY2018 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-56000
CY2018 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-48491000
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
85038000
CY2018 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
82666000
CY2018 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
244000
CY2018 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4317000
CY2019 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
56997000
CY2019 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
22874000
CY2019 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4134000
CY2019 us-gaap Profit Loss
ProfitLoss
-51373000
CY2019 us-gaap Depreciation
Depreciation
2702000
CY2018 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-8000
CY2019 sybx Reduction In Carrying Amount Of Operating Lease Right Of Use Asset
ReductionInCarryingAmountOfOperatingLeaseRightOfUseAsset
1370000
CY2019 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
12263000
CY2019 sybx Increase Decrease In Prepaid Research And Development Net Of Current Portion
IncreaseDecreaseInPrepaidResearchAndDevelopmentNetOfCurrentPortion
-16381000
CY2019 us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
157465000
CY2018 us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
91340000
CY2019 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1251000
CY2018 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
5654000
CY2019 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
10796000
CY2018 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-87201000
CY2019 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
266000
CY2018 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
427000
CY2018 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
244000
CY2019 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
56996000
CY2018 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
82666000
CY2019 us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
22874000
CY2018 us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
2843000
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
124098000
CY2018Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
140340000
CY2019 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
79604000
CY2019 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
14932000
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
12349000
CY2018 sybx Allowance For Tenant Improvements
AllowanceForTenantImprovements
1654000
CY2019 sybx Noncash Purchase Of Property Plant And Equipment In Accounts Payable And Accrued Liabilities Adjustments
NoncashPurchaseOfPropertyPlantAndEquipmentInAccountsPayableAndAccruedLiabilitiesAdjustments
-369000
CY2019 sybx Assets Acquired Under Operating Lease Obligation
AssetsAcquiredUnderOperatingLeaseObligation
2714000
CY2019 us-gaap Interest Paid Net
InterestPaidNet
21000
CY2018 sybx Assets Acquired Under Capital Leases
AssetsAcquiredUnderCapitalLeases
12000
CY2018Q4 us-gaap Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
1339000
CY2019 us-gaap Use Of Estimates
UseOfEstimates
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Use of Estimates</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of financial statements in accordance with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of expenses during the reporting period.&nbsp;&nbsp;On an on-going basis, the Company&#8217;s management evaluates its estimates, including those related to revenue recognition, income taxes including the valuation allowance for deferred tax assets, research and development accruals and prepaids, accrued expenses, investments, contingencies and equity-based compensation. The Company bases its estimates on historical experience and on various other assumptions that are believed to be reasonable, the results of which form the basis for making judgments about the carrying values of assets and liabilities. Actual results could differ from those estimates.&nbsp;&nbsp;Changes in estimates are reflected in reported results in the period in which they become known.</p>
CY2019 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Concentration of Credit Risk</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Financial instruments that potentially subject the Company to concentrations of credit risk include amounts held as cash, cash equivalents, marketable securities and restricted cash. The Company uses high quality, accredited financial institutions to maintain its balances, and accordingly, such funds are subject to minimal credit risk. The Company has not experienced any losses in such accounts and management believes that the Company is not exposed to significant credit risk due to the financial position of the depository institutions in which those deposits are held. The Company has no financial instruments with off-balance sheet risk of loss.</p>
CY2018Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
5000
CY2019 us-gaap Property Plant And Equipment Impairment
PropertyPlantAndEquipmentImpairment
<p style="margin-top:8pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Impairment of Long&#8209;Lived Assets</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Long&#8209;lived assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of the asset may not be recoverable. When such events occur, the Company compares the carrying amounts of the assets to their undiscounted expected future cash flows. If this comparison indicates that there is impairment, the amount of impairment is calculated as the difference between the carrying value and fair value of the asset. To date, no such impairments have been recognized.</p>
CY2018Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
597000
CY2019Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
24000000
CY2019Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
100777000
CY2018Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
111542000
CY2019Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
116000
CY2019 us-gaap Revenue Practical Expedient Remaining Performance Obligation Description
RevenuePracticalExpedientRemainingPerformanceObligationDescription
The Company recognizes as an asset the incremental costs of obtaining a contract with a customer if the costs are expected to be recovered. As a practical expedient, the Company recognizes the incremental costs of obtaining a contract as an expense when incurred if the amortization period of the asset that we otherwise would have recognized is one year or less. To date, the Company has not incurred any incremental costs of obtaining a contract with a customer
CY2019Q4 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
119600000
CY2019Q4 us-gaap Marketable Securities Noncurrent
MarketableSecuritiesNoncurrent
7500000
CY2019 us-gaap Additional Cash And Cash Equivalent Related Text
AdditionalCashAndCashEquivalentRelatedText
three months or less
CY2019Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
13500000
CY2018Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
300000
CY2019Q4 us-gaap Cash Collateral For Borrowed Securities
CashCollateralForBorrowedSecurities
1097000
CY2018Q4 us-gaap Cash Collateral For Borrowed Securities
CashCollateralForBorrowedSecurities
1097000
CY2019 sybx Fair Value Asset Liability Transfers Between Level1 Level2 And Level3 Amount
FairValueAssetLiabilityTransfersBetweenLevel1Level2AndLevel3Amount
0
CY2018 sybx Fair Value Asset Liability Transfers Between Level1 Level2 And Level3 Amount
FairValueAssetLiabilityTransfersBetweenLevel1Level2AndLevel3Amount
0
CY2019 us-gaap Tangible Asset Impairment Charges
TangibleAssetImpairmentCharges
0
CY2019 us-gaap Revenue Practical Expedient Incremental Cost Of Obtaining Contract
RevenuePracticalExpedientIncrementalCostOfObtainingContract
true
CY2019 us-gaap Income Tax Examination Likelihood Of Unfavorable Settlement
IncomeTaxExaminationLikelihoodOfUnfavorableSettlement
greater than 50%
CY2019 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2019 us-gaap Lease Practical Expedients Package
LeasePracticalExpedientsPackage
true
CY2019 us-gaap Lessee Operating Lease Existence Of Option To Extend
LesseeOperatingLeaseExistenceOfOptionToExtend
true
CY2019 us-gaap Lessee Operating Lease Option To Extend
LesseeOperatingLeaseOptionToExtend
options to extend the lease when it is reasonably certain that option will be exercised
CY2019Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
15900000
CY2017Q3 sybx Common Stock Exchange Ratio
CommonStockExchangeRatio
0.5532
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
4.59
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
6.35
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
3900000
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
3300000
CY2019Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
6800000
CY2019 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y4M24D
CY2019 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
4134000
CY2018 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
4317000
CY2019 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2018 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2019Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
46362000
CY2018Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
33275000
CY2019Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
4262000
CY2019Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
4000
CY2018Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
70000
CY2019Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
100889000
CY2018Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
111477000
CY2019Q4 us-gaap Debt Securities Available For Sale Unrealized Loss Position Number Of Positions
DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
9
CY2019Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Number Of Positions
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions
0
CY2019Q4 us-gaap Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
24800000
CY2018Q4 us-gaap Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
96500000
CY2019Q4 sybx Other Than Temporary Impairment Losses Investments Number Debt Securities Available For Sale
OtherThanTemporaryImpairmentLossesInvestmentsNumberDebtSecuritiesAvailableForSale
0
CY2019Q4 us-gaap Prepaid Insurance
PrepaidInsurance
648000
CY2018Q4 us-gaap Prepaid Insurance
PrepaidInsurance
502000
CY2019Q4 sybx Prepaid Research And Development Current
PrepaidResearchAndDevelopmentCurrent
11989000
CY2018Q4 sybx Prepaid Research And Development Current
PrepaidResearchAndDevelopmentCurrent
122000
CY2019Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
390000
CY2019Q4 us-gaap Other Assets Current
OtherAssetsCurrent
648000
CY2018Q4 us-gaap Other Assets Current
OtherAssetsCurrent
388000
CY2019Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
18652000
CY2018Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
17828000
CY2019Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
5631000
CY2018Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2987000
CY2019 sybx Number Of Votes Entitled To Each Share Of Common Stock
NumberOfVotesEntitledToEachShareOfCommonStock
1
us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
0
CY2018Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
53800000
CY2018Q2 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
28900000
CY2018Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
4365000
CY2019Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
37000
CY2018Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
103000
CY2018Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Deferred Rent
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent
2209000
CY2019Q4 sybx Deferred Tax Assets Lease Liabilities
DeferredTaxAssetsLeaseLiabilities
6776000
CY2019Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
1481000
CY2018Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
784000
CY2019Q4 us-gaap Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
1214000
CY2019Q4 sybx Deferred Tax Liabilities Right Of Use Assets
DeferredTaxLiabilitiesRightOfUseAssets
4716000
CY2019Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
6436000
CY2018Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
1863000
CY2019Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
53834000
CY2018Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
40290000
CY2019 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2018 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2017Q3 sybx Operating Leases Rent Expense Annual Rental Payments
OperatingLeasesRentExpenseAnnualRentalPayments
3100000
CY2019 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.06
CY2018 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.06
CY2019 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Other
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther
-0.01
CY2018 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Other
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther
-0.01
CY2019 us-gaap Effective Income Tax Rate Reconciliation Tax Credits
EffectiveIncomeTaxRateReconciliationTaxCredits
0.00
CY2018 us-gaap Effective Income Tax Rate Reconciliation Tax Credits
EffectiveIncomeTaxRateReconciliationTaxCredits
0.03
CY2019 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0.00
CY2018 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
-0.01
CY2019 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.26
CY2017Q3 us-gaap Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
P10Y
CY2017Q3 sybx Tenant Improvement Investment Obligation
TenantImprovementInvestmentObligation
2900000
CY2017Q3 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
1000000
CY2017Q3 us-gaap Lessee Operating Lease Existence Of Option To Extend
LesseeOperatingLeaseExistenceOfOptionToExtend
true
CY2017Q3 us-gaap Lessee Operating Lease Renewal Term
LesseeOperatingLeaseRenewalTerm
P5Y
CY2019Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
138000
CY2018Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
78000
CY2019Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
60270000
CY2018Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
42153000
CY2019Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
1720000
CY2018Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
1863000
CY2017Q3 us-gaap Lessee Operating Lease Existence Of Option To Terminate
LesseeOperatingLeaseExistenceOfOptionToTerminate
true
CY2018Q4 sybx Agreement Expiration Date
AgreementExpirationDate
2022-12-31
CY2019 us-gaap Operating Lease Payments
OperatingLeasePayments
3700000
CY2019 us-gaap Operating Lease Cost
OperatingLeaseCost
3344000
CY2019 us-gaap Short Term Lease Cost
ShortTermLeaseCost
330000
CY2019 us-gaap Variable Lease Cost
VariableLeaseCost
1092000
CY2019 sybx Operating And Variable Lease Cost
OperatingAndVariableLeaseCost
4766000
CY2019 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
188000
CY2019 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
21000
CY2018 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.28
CY2017Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
26515000
CY2019 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
13544000
CY2018 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
13775000
CY2019Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2019 us-gaap Income Tax Examination Description
IncomeTaxExaminationDescription
In the normal course of business, the Company is subject to examination by federal and state jurisdictions, where applicable. There are currently no pending tax examinations. Tax years from 2016 to the present are open to examination under the statute.
CY2019Q4 us-gaap Income Tax Examination Penalties And Interest Accrued
IncomeTaxExaminationPenaltiesAndInterestAccrued
0
CY2018Q4 us-gaap Income Tax Examination Penalties And Interest Accrued
IncomeTaxExaminationPenaltiesAndInterestAccrued
0
CY2017Q3 sybx Rentable Space Under Lease Agreement
RentableSpaceUnderLeaseAgreement
41346
CY2019 sybx Finance Lease Cost
FinanceLeaseCost
209000
CY2019 us-gaap Lease Cost
LeaseCost
4975000
CY2019Q4 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
900000
CY2019Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.080
CY2019Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P8Y2M12D
CY2019Q4 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.061
CY2019Q4 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P9M18D
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
3892000
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
4236000
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
4389000
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
3574000
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
3681000
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
14386000
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
34158000
CY2019Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
9354000
CY2019Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
24804000
CY2019Q4 us-gaap Finance Lease Liability Payments Due Next Twelve Months
FinanceLeaseLiabilityPaymentsDueNextTwelveMonths
214000
CY2019Q4 us-gaap Finance Lease Liability Payments Due Year Two
FinanceLeaseLiabilityPaymentsDueYearTwo
2000
CY2019Q4 us-gaap Finance Lease Liability Payments Due
FinanceLeaseLiabilityPaymentsDue
216000
CY2019Q4 us-gaap Finance Lease Liability Undiscounted Excess Amount
FinanceLeaseLiabilityUndiscountedExcessAmount
6000
CY2019Q4 us-gaap Finance Lease Liability
FinanceLeaseLiability
210000
CY2019 us-gaap Defined Contribution Plan Employer Matching Contribution Percent Of Match
DefinedContributionPlanEmployerMatchingContributionPercentOfMatch
0.50
CY2019 us-gaap Defined Contribution Plan Maximum Annual Contributions Per Employee Percent
DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent
0.04
CY2019 us-gaap Defined Contribution Plan Employer Matching Contribution Percent
DefinedContributionPlanEmployerMatchingContributionPercent
0.02
CY2019Q1 us-gaap Revenues
Revenues
338000
CY2019Q2 us-gaap Revenues
Revenues
350000
CY2019Q3 us-gaap Revenues
Revenues
305000
CY2019Q4 us-gaap Revenues
Revenues
1231000
CY2019Q1 us-gaap Operating Expenses
OperatingExpenses
14035000
CY2019Q2 us-gaap Operating Expenses
OperatingExpenses
13445000
CY2019Q3 us-gaap Operating Expenses
OperatingExpenses
14443000
CY2019Q4 us-gaap Operating Expenses
OperatingExpenses
14710000
CY2019Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-13697000
CY2019Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-13095000
CY2019Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-14138000
CY2019Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-13479000
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
-12946000
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
-12344000
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
-13285000
CY2019Q4 us-gaap Net Income Loss
NetIncomeLoss
-12798000
CY2019Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.51
CY2019Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.45
CY2019Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.39
CY2019Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.37
CY2018Q1 us-gaap Revenues
Revenues
354000
CY2018Q2 us-gaap Revenues
Revenues
254000
CY2018Q3 us-gaap Revenues
Revenues
1801000
CY2018Q4 us-gaap Revenues
Revenues
111000
CY2018Q1 us-gaap Operating Expenses
OperatingExpenses
11990000
CY2018Q2 us-gaap Operating Expenses
OperatingExpenses
15606000
CY2018Q3 us-gaap Operating Expenses
OperatingExpenses
13335000
CY2018Q4 us-gaap Operating Expenses
OperatingExpenses
12819000
CY2018Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-11636000
CY2018Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-15352000
CY2018Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-11534000
CY2018Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-12708000
CY2018Q1 us-gaap Net Income Loss
NetIncomeLoss
-11165000
CY2018Q2 us-gaap Net Income Loss
NetIncomeLoss
-14591000
CY2018Q3 us-gaap Net Income Loss
NetIncomeLoss
-10748000
CY2018Q4 us-gaap Net Income Loss
NetIncomeLoss
-11931000
CY2018Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.55
CY2018Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.59
CY2018Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.43
CY2018Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.47

Files In Submission

Name View Source Status
0001564590-20-010261-index-headers.html Edgar Link pending
0001564590-20-010261-index.html Edgar Link pending
0001564590-20-010261.txt Edgar Link pending
0001564590-20-010261-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
gyvsmyqxnyhu000001.jpg Edgar Link pending
gyvsmyqxnyhu000002.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
sybx-10k_20191231.htm Edgar Link pending
sybx-20191231.xml Edgar Link completed
sybx-20191231.xsd Edgar Link pending
sybx-20191231_cal.xml Edgar Link unprocessable
sybx-20191231_def.xml Edgar Link unprocessable
sybx-20191231_lab.xml Edgar Link unprocessable
sybx-20191231_pre.xml Edgar Link unprocessable
sybx-ex211_6.htm Edgar Link pending
sybx-ex231_14.htm Edgar Link pending
sybx-ex311_8.htm Edgar Link pending
sybx-ex312_11.htm Edgar Link pending
sybx-ex321_13.htm Edgar Link pending
sybx-ex322_15.htm Edgar Link pending
sybx-ex43_732.htm Edgar Link pending